Search filters

List of works by Fabrice André

19q13-ERCC1 gene copy number increase in non--small-cell lung cancer

scientific article published on 15 June 2013

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

scientific article published on 19 February 2017

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

scientific article

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).

scientific article

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

scientific article published on 01 August 2018

A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers

scientific article published on 14 June 2017

A Systematic Evaluation of Blood Serum and Plasma Pre-Analytics for Metabolomics Cohort Studies

scientific article published on 05 December 2016

A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency

scientific article published on 12 October 2020

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

scientific article

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

scientific article published in September 2018

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

scientific article published on 25 October 2017

A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer

scientific article published on 12 August 2013

A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes

scientific article published on 16 February 2012

A nomogram to predict for malignant diagnosis of BI-RADS Category 4 breast lesions

scientific article published on 01 September 2010

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy

scientific article

A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer

scientific article published on 25 January 2019

A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer.

scientific article

ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics

scientific article published on 8 February 2013

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

scientific article (publication date: October 2009)

Adapting the drivers to the road: a new strategy for cancer evolution?

scientific article

Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors

scientific article published on 01 July 2018

Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer

scientific article published on April 2014

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer

scientific article published on 01 May 2019

Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.

scientific article

An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells

scientific article published on 16 December 2019

Annals of Oncology: factors for making a real impact

scientific article published on 01 January 2018

Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer

scientific article published on 26 July 2012

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca

scientific article published on 2 August 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in I

scientific article published in September 2017

Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer

scientific article published on 11 January 2012

BOLERO-3 results: pharmacological activity or pharmacokinetic effect?--authors' reply

scientific article published on 01 July 2014

Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer.

scientific article

Bevacizumab: the phoenix of breast oncology?

scientific article published on 11 May 2015

Biogenesis of alpha6beta4 integrin in a human colonic adenocarcinoma cell line involvement of calnexin

scientific article published on May 1999

Biology-driven phase II trials: what is the optimal model for molecular selection?

scientific article published on 22 February 2011

Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groups.

scientific article published on March 2012

Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

scientific article

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors

scientific article published on April 2001

Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy.

scientific article

Breast cancer in Sub-Saharan African women: review

scientific article published in July 2011

Breast cancer screening: On our way to the future

scientific article

Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors

scientific article published on 01 September 2004

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

scientific article

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death

scientific article

Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging

scientific article published in April 2010

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

scientific article published on 29 October 2015

Chk1 as a new therapeutic target in triple-negative breast cancer

scientific article published on 15 March 2014

Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial

scientific article published on 12 January 2016

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizuma

scientific article published in January 2017

Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses

scientific article published on 23 January 2012

Cognitive impairment in breast cancer patients before surgery: results from a CANTO cohort subgroup

scientific article published on 01 July 2020

Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers

scientific article published on 17 June 2008

Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.

scientific article published on 16 June 2015

Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis

scientific article published on 27 October 2018

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer

scientific article published on October 2015

Combining PI3K and PARP inhibitors for breast and ovarian cancer treatment.

scientific article published in June 2017

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

scientific article published on 7 February 2014

Consensus on precision medicine for metastatic cancers: a report from the MAP conference.

scientific article published on 3 May 2016

Correction: ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

scientific article published on 01 February 2019

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259].

scientific article published on 18 January 2017

Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung Cancers

scientific article published on 11 July 2016

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

scientific article published on 01 August 2020

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer

scientific article published on 26 February 2019

Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers

scientific article published on 12 March 2010

DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: current data and issues on study design.

scientific article published on 9 August 2006

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

scientific article

DNA repair capacity in circulating lymphocytes and influence on platinum effect in tumor cells

scientific article published on 19 March 2012

DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.

scientific article published on 26 September 2013

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

scientific article published on 01 August 2017

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

scientific article published on 01 October 2018

Deciphering root causes of intrinsic BRAF inhibitor resistance in melanoma: ushering in a new genomics case reports feature for Annals of Oncology

scientific article

Decision-making from multidisciplinary team meetings to the bedside: factors influencing the recruitment of breast cancer patients into clinical trials

scientific article published on 08 January 2014

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

scientific article published on 28 June 2013

Defining research priorities without biases: what is the optimal process?

scientific article published on 01 February 2017

Dendritic cell derived-exosomes: biology and clinical implementations

scientific article published on 29 June 2006

Dendritic cell-derived exosomes as immunotherapies in the fight against cancer

scientific article

Dendritic cell-derived exosomes for cancer therapy

scientific article published on April 2016

Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha

scientific article

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

scientific article

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study

scientific article published on 01 March 2007

Developing Anticancer Drugs in Orphan Molecular Entities - A Paradigm under Construction

scientific article published on 01 February 2018

Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution

scientific article

Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers

scientific article published on 17 June 2012

Disease management patterns for postmenopausal women in Europe with hormone-receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer

scientific article published on 03 February 2014

Distinct tumor protein p53 mutants in breast cancer subgroups

scientific article

Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers

scientific article

Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.

scientific article published on 4 October 2013

EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients

scientific article

ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

scientific article published on 26 March 2018

ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform

scientific article

ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy

scientific article published on 26 August 2010

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer

scientific article

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

scientific article

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

scientific article

Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer.

scientific article

Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index

scientific article published on 09 June 2021

Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer

scientific article published on 14 September 2007

Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers.

scientific article published on 12 January 2018

Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis.

scientific article published on 22 February 2013

Escherichia coli-specific CXCL13-producing TFH are associated with clinical efficacy of neoadjuvant PD-1 blockade against muscle-invasive bladder cancer

scientific article published in 2022

Estrogen receptor expression and docetaxel efficacy in patients with metastatic breast cancer: a pooled analysis of four randomized trials.

scientific article published on 26 April 2010

Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis.

scientific article published in June 2008

Evaluating beauty care provided by the hospital to women suffering from breast cancer: qualitative aspects.

scientific article

Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansi

scientific article published on 21 November 2016

Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedure.

scientific article

Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial

scientific article published on 10 August 2009

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

scientific article published on 14 April 2014

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients

scientific article published on 01 December 1998

Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis

scientific article published on 25 February 2009

Exosome-based immunotherapy

scientific article published on 16 January 2004

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells

scientific article published on February 2004

Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection

scientific article published on February 2004

Expression of chemokine receptor CCR6 as a molecular determinant of adrenal metastatic relapse in patients with primary lung cancer

scientific article published on 01 May 2010

Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer

scientific article published on 05 September 2007

Fatigue and physical activity in cancer survivors: A cross-sectional population-based study.

scientific article published on 12 March 2019

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy

scientific article published on 08 September 2020

From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes.

scientific article

Funding sources of practice changing trials

scientific article published on 15 December 2017

Gene copy number variations in breast cancer of Sub-Saharan African women

scientific article published on 19 September 2012

Gene expression predictors in breast cancer: current status, limitations and perspectives

scientific article

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

scientific article

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

scientific article published on 29 December 2010

Genomes in the clinic: the Gustave Roussy Cancer Center experience

scientific article published on 26 February 2014

Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

scientific article published on 01 March 2019

Genomic characterization of metastatic breast cancers

scientific article published on 22 May 2019

Genomic index of sensitivity to endocrine therapy for breast cancer.

scientific article

HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.

scientific article published on 28 April 2007

Her2-neu: a target in lung cancer?

scientific article published on 01 January 2004

Heterogeneity of breast cancer among patients and implications for patient selection for adjuvant chemotherapy.

scientific article published on 12 August 2006

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

scientific article published on 01 April 2017

Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?

scientific article published on 26 March 2013

Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door

scientific article published on 27 January 2018

Immune responses during COVID-19 infection

scientific article published on 25 August 2020

Immunodynamics of explanted human tumors for immuno-oncology

scientific article published on 29 December 2020

Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy

scientific article published on 31 August 2015

Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy?

scientific article

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

scientific article published on 30 July 2020

Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncology.

scientific article published on 18 June 2013

Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology

scientific article

Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients ⬇️

scientific article published on November 1, 2010

Implications of personalized medicine--perspective from a cancer center

scientific article published on 01 March 2011

Improving the Performance of Somatic Mutation Identification by Recovering Circulating Tumor DNA Mutations

scientific article

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers

scientific article published on 10 February 2007

Integration of host-related signatures with cancer cell-derived predictors for the optimal management of anticancer chemotherapy

scientific article

Integrin ligation and PKC activation are required for migration of colon carcinoma cells ⬇️

scientific article published on October 1, 1998

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment

scientific article published on 07 May 2021

Issues in clinical research for metastatic breast cancer

scientific article

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

scientific article

Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer

scientific article published on 20 April 2009

Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy

scientific article published on 01 February 2007

Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA.

scientific article published on 23 April 2015

Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer

scientific article published on 01 April 2007

Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer

scientific article published on 01 May 2005

Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial

scientific article published on 01 August 2018

Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3.

scientific article

Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.

scientific article

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

scientific article published on 30 August 2010

Molecular biology in breast cancer: should molecular classifiers be assessed by conventional tools or by gene expression arrays?

scientific article published on 07 September 2012

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

scientific article

Molecular circuits of solid tumors: prognostic and predictive tools for bedside use.

scientific article published on 15 June 2010

Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.

scientific article published on November 2006

Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.

scientific article published on 20 December 2012

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.

scientific article published on December 2012

Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program

scientific article published on 01 July 2007

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.

scientific article

Natural and therapy-induced immunosurveillance in breast cancer

scientific article published on October 2015

Natural history, management and pharmacokinetics of everolimus-induced-oral ulcers: insights into compliance issues.

scientific article

New strategies to overcome resistance to mammalian target of rapamycin inhibitors in breast cancer.

scientific article

News from the San Antonio Breast Cancer Symposium 2018

scientific article published on 13 February 2019

Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer

scientific article

Nuclear localization of the caspase-3-cleaved form of p73 in anoikis

scientific article published on 26 October 2015

Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands

scientific article

Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents

scientific article

Outcome in breast molecular subtypes according to nodal status and surgical procedures.

scientific article

P53 family: at the crossroads in cancer therapy

scientific article published on January 2009

PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs

scientific article published on 12 February 2013

Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results

scientific article

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer

scientific article

Patterns of resource utilization and cost for postmenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer in Europe

scientific article published on 24 October 2015

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial

scientific article published on 11 February 2019

Peritoneal carcinomatosis in germ-cell tumor: relations with retroperitoneal lymph node dissection

scientific article published on 01 October 2000

Persistence of viable tumor cells after radiation and chemotherapy for stage IIIB non-small cell lung cancer: an early marker of treatment failure

scientific article published on 01 February 2001

Personalized medicine in oncology: where have we come from and where are we going?

scientific article published in June 2013

Pervasive chromosomal instability and karyotype order in tumour evolution

scientific article published on 02 September 2020

Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With Trastuzumab ⬇️

scientific article published on October 25, 2010

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors

scientific article (publication date: November 2014)

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy

scientific article published on 10 February 2017

Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.

scientific article published on 06 June 2016

Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer.

scientific article

Precision medicine for metastatic breast cancer--limitations and solutions.

scientific article published on 21 July 2015

Precision medicine for metastatic breast cancer.

scientific article published on January 2015

Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status

scientific article published in October 2009

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

scientific article published on 20 May 2015

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

scientific article published on 08 January 2014

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

scientific article published on July 2015

Progresses toward precision medicine in RET-altered solid tumors

scientific article published on 14 July 2020

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

scientific article published on 06 July 2021

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

scientific article published on 17 September 2020

Rationale for targeting fibroblast growth factor receptor signaling in breast cancer

scientific article

Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elements.

scientific article published on 24 November 2017

Reply to D.C. Sgroi et al, T. Sanft et al, M.S. Copur et al, and M.P. Goetz et al

scientific article published on 01 November 2016

Reproducibility of research and preclinical validation: problems and solutions.

scientific article published in October 2013

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome

scientific article published on 01 July 2007

Resistance to HER2 inhibitors: is addition better than substitution? Rationale for the hypothetical concept of drug sedimentation

scientific article published on June 2010

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

scientific article published on 4 February 2008

Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers

scientific article published on 3 July 2013

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

scientific article published on 7 October 2016

Risk factors for brain relapse in patients with metastatic breast cancer

scientific article published on 01 November 2004

Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion

scientific article published on 17 February 2022

Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases

scientific article published on 21 June 2005

Statistical controversies in clinical research: statistical significance-too much of a good thing ….

scientific article published on 09 February 2016

Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials.

scientific article

Supervision after breast cancer treatment

scientific article published in December 2013

Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications

scientific article published on 01 August 2000

TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer

scientific article published on 22 February 2011

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.

scientific article published on 5 January 2014

Targeted therapies for ER+/HER2- metastatic breast cancer

scientific article published on 9 June 2015

Targeting FGFR Signaling in Cancer

scientific article published on June 2015

Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer

scientific article

Targeting TCTP with Sertraline and Thioridazine in Cancer Treatment

scientific article published in January 2017

Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy

scientific article

The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy.

scientific article published on 13 October 2016

The anticancer immune response: indispensable for therapeutic success?

scientific article published on June 2008

The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic

scientific article

The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: the case of the Institut Gustave Roussy ⬇️

scientific article published on 16 March 2012

The genetic landscape and clonal evolution of breast cancer resistance to palbociclib plus fulvestrant in the PALOMA-3 trial

scientific article published on 11 September 2018

The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients

scientific article published on 01 July 2000

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

scientific article published on December 2007

The potential of exosomes in immunotherapy

scientific article

The potential of exosomes in immunotherapy of cancer

scientific article

The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer

scientific article published on 16 March 2016

The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ

scientific article published on 18 August 2016

Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape

scientific article

Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistance

scientific article published on January 2016

Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization?

scientific article published on October 2010

Triple-negative breast cancer: are we making headway at least? ⬇️

scientific article published on July 1, 2012

Tumor genotyping for breast cancer: at the front door

scientific article published on 01 July 2011

Tumor resistance to HER2 inhibitors: the drug sedimentation concept

scientific article published in June 2012

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

scientific article published on 16 January 2019

Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers

scientific article published on 22 December 2014

Tumor-specific circulating angiogenic progenitors in breast and renal cell cancer: What prospects?

scientific article published on 8 April 2017

TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen

scientific article (publication date: October 2015)

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

scientific article

Use of guidelines and heterogeneity of decision making for adjuvant chemotherapy in hormone-receptor positive, HER2-negative, early breast cancer: results of a French national survey

scientific article published in October 2014

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement

scientific article

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

scientific article

What can be done for patients with NSCLC without druggable targets? ⬇️

scientific article published on March 1, 2013

What can breast cancer molecular sub-classification add to conventional diagnostic tools?

scientific article published on July 2007

What to expect from high throughput genomics in metastatic breast cancers?

scientific article published on 01 August 2015

Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients

scientific article published on 21 November 2017

Whole exome sequencing of rare aggressive breast cancer histologies.

scientific article

[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]]

scientific article published on 28 October 2016

[Her2 a paradigm for targeted therapy].

scientific article

mTOR inhibitors in advanced breast cancer: ready for prime time?

scientific article published on April 2013

mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions.

scientific article published on 02 May 2012

p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes

scientific article published on 5 March 2008

rCGH: a comprehensive array-based genomic profile platform for precision medicine

scientific article published on 26 December 2015

Paulina is supported by:

About Paulina

Help